Skip to main content

Xenobiotic Interactions in Psychopharmacotherapy: Classification and Handling

  • Living reference work entry
  • First Online:
NeuroPsychopharmacotherapy

Abstract

Drug-drug-interactions (DDI) are a major topic in programs for continuous medical education (CME). Lectures on this topic usually attract a great audience. Many physicians are afraid of being trapped in charges with malpractice. The idea that a drug-drug interaction is evidence of medical malpractice supports this notion. Some computer databases accessible via internet feed this anxiety by presenting a red exclamation mark if a “drug-drug interaction” is detected in a patient’s medication. Even worse is to categorize this warning like a traffic light. The medical problem is not the drug-drug interaction (DDI) but the adverse drug effect (ADE) that arises from a drug-drug interaction in the individual patient! DDI belong to routine medical practice, and it is often impossible to avoid them. Moreover, they do not just occur between drugs but between any kind of foreign substances (xenobiotica), such as food as well as legal (tobacco smoke, caffeine, alcohol) and illegal drugs. Therefore, the medical challenge is not to just avoid any interaction. Instead, the physician faces the question how to proceed with drug treatment in the presence of such interactions. Based on their medical education, the physician has to judge first of all by themself whether there is a risk for interactions in the prescription they are planning for an individual patient. The classification of interactions into just seven categories proposed in this chapter might hereby help as a sort of checklist. For information that is more detailed, the physician can then consult one of the databases that address the risk for ADE, such as PSIAC (www.psiac.de) or MediQ (www.mediq.ch). Pharmacokinetic interactions may be easily assessed, monitored, and controlled by therapeutic drug monitoring (TDM). Besides these tools, it is important to keep in mind that nobody knows everything; even physicians do not know everything. So take pride in asking someone who might help. For this purpose, AGATE offers its drug information service AID (www.amuep-agate.de). Just good for nothing are computer programs without any kind of medical basis that judge prescriptions without taking into account a patient’s individual peculiarities. In case these types of programs produce red exclamation marks or traffic lights to underline their judgment, they might even work contrapuntal by just eliciting insecurity and terror.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Ahmad A, Shahabuddin S, Sheikh S, Kale P, Krishnappa M, Rane RC, Ahmad I. Endoxifen, a new cornerstone of breast cancer therapy: demonstration of safety, tolerability, and systemic bioavailability in healthy human subjects. Clin Pharmacol Ther. 2010;88(6):814–7.

    Article  CAS  PubMed  Google Scholar 

  • ABDATA for pharmacies Avoxa – Mediengruppe Deutscher Apotheker GmbH, Eschborn. n.d.-a. Accessible via https://abdata.de/datenangebot/abda-datenbank. Accessed 26 Jan 2020.

  • ABDAMED for medical practitioners Avoxa – Mediengruppe Deutscher Apotheker GmbH, Eschborn. n.d.-b. Accessible via https://abdata.de/datenangebot/abdamed. Accessed 26 Jan 2020.

  • Barry PJ, O’Keefe N, O’Connor KA, O’Mahony D. Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the improved prescribing in the elderly tool (IPET) in acutely ill elderly hospitalized patients. J Clin Pharm Ther. 2006;31(6):617–26.

    Article  CAS  PubMed  Google Scholar 

  • Bayer Vital GmbH Leberkusen/Germany. Fachinformation (Summary of Product Characteristics) Saroten® retard Tabs 75 mg. (2018). issued Nov 2018.

    Google Scholar 

  • Boehr S, Haen E. Development of an UHPLC-UV-method for quantification of direct oral anticoagulants: apixaban, rivaroxaban, dabigatran, and its prodrug dabigatran etexilate in human serum. Ther Drug Monit. 2017;39(1):66–76.

    Article  CAS  PubMed  Google Scholar 

  • Corsonello A, Pranno L, Garasto S, Fabietti P, Bustacchini S, Lattanzio F. Potentially inappropriate medication in elderly hospitalized patients. Drugs Aging. 2009;26(Suppl 1):31–9.

    Article  PubMed  Google Scholar 

  • Desitin Arzneimittel GmbH Hamburg, Germany. Fachinformation (Summary of Product Information) Orfiril® magensaftresistentes (gastro-fluid resistant) Dragee 155, 300 und 600 mg. 2016, issued Nov 2016.

    Google Scholar 

  • Deutsches Institut für Medizinische Dokumentation und Information (DIMDI), Köln. 2020. Accessible via https://www.dimdi.de/dynamic/de/arzneimittel. Accessed 26 Jan 2020.

  • Eckermann G, Haen E, Hiemke C, editors. PSIAC – polymedication under control. Heidelberg: Springer; 2020. Accessible via https://www.psiac.de. Accessed 27 Jan 2020.

    Google Scholar 

  • Endres K, Haen E. The dose-related reference range – a new approach with improved predictive quality. Pharmacopsychiatry. 2020;53(3):140–1.

    Article  Google Scholar 

  • Fichtl B. Arzneistoffkonzentration im Organismus in Abhängigkeit von der Zeit: Pharmakokinetik im engeren Sinn. In: Forth W, Henschler D, Rummel W, Förstermann U, Starke K, editors. Allgemeine und Spezielle Pharmakologie und Toxikologie. 8th ed. München/Jena: Urban & Fischer Verlag; 2001. p. 72–4.

    Google Scholar 

  • Geisslinger G, Menzel S, Gudermann T, Hinz B, Ruth P, editors. Mutschler Arzneimittelwirkungen. 11th ed. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 2020. p. 1002.

    Google Scholar 

  • Gex-Fabry M, Balant-Gorgia AE, Balant LP. Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication. Ther Drug Monit. 2003;25:46–53.

    Article  CAS  PubMed  Google Scholar 

  • Haen E. Bedeutung der klinisch-pharmakologischen Befundung von Wirkstoffkonzentrationsmessungen zur Therapieleitung. Psychopharmakotherapie. 2005;12:138–43.

    Google Scholar 

  • Haen E. Der Klinikverbund AGATE: Ein Pharmakokompetenzzentrum flächendeckend in und für Bayern. Bayer Aztebl. 2010;65(12):702–3.

    Google Scholar 

  • Haen E. Therapeutic drug monitoring in pharmacovigilance and pharmacotherapy safety. Pharmacopsychiatry. 2011;44:254–8.

    Article  CAS  PubMed  Google Scholar 

  • Haen E. Der TDM-Befund. Psychopharmakotherapie. 2012;19:129–34.

    Google Scholar 

  • Haen E. Arzneimittelinteraktionen – Interaktionen zwischen körperfremden Substanzen. Nervenarzt. 2014;85:417–26.

    Article  CAS  PubMed  Google Scholar 

  • Haen E. Interaktionen von Xenobiotika. In: Klein HG, Haen E, editors. Pharmakogenetik und Therapeutisches Drug Monitoring. Berlin/Boston: Walter de Gruyter GmbH; 2018a. p. 32–44. ISBN 978-3-11-035286-3; e-ISBN (PDF) 978-3-11-035290-0, e-ISBN (EPUB) 978-3-11-038780-3.

    Google Scholar 

  • Haen E. Pharmakodynamik. In: Klein HG, Haen E, editors. Pharmakogenetik und Therapeutisches Drug Monitoring. Berlin/Boston: Walter de Gruyter GmbH; 2018b. p. 20–31. ISBN 978-3-11-035286-3; e-ISBN (PDF) 978-3-11-035290-0, e-ISBN (EPUB) 978-3-11-038780-3.

    Google Scholar 

  • Haen E. Concentratio, non dosis facit venenum. In: Klein HG, Haen E, editors. Pharmakogenetik und Therapeutisches Drug Monitoring. Berlin/Boston: Walter de Gruyter GmbH; 2018c. p. 159–61. ISBN 978-3-11-035286-3, e-ISBN (PDF) 978-3-11-035290-0, e-ISBN (EPUB) 978-3-11-038780-3.

    Google Scholar 

  • Haen E. Der klinisch-pharmakologische Befund zu Wirkstoffkonzentrationen (TDM-Befund). In: Klein HG, Haen E, editors. Pharmakogenetik und Therapeutisches Drug Monitoring. Berlin/Boston: Walter de Gruyter GmbH; 2018d. p. 131–46. ISBN 978-3-11-035286-3, e-ISBN (PDF) 978-3-11-035290-0, e-ISBN (EPUB) 978-3-11-038780-3.

    Google Scholar 

  • Haen E. Olanzapine and diazepam. In: Eckermann G, Haen E, Hiemke C, editors. PSIAC – polymedication under control. Internet based data base of drug-drug-interactions. Berlin/Heidelberg: Springer; 2019. https://www.psiac.de/interaction/query/A197+A240. Accessed 11 Dec 2019.

    Google Scholar 

  • Haen E. Channelopathy: individualised pharmacotherapy in aquired long QT syndrome. Päd Praxis. 2020;93:269–75.

    Google Scholar 

  • Haen E, Emslander HP. Chronisch obstruktive Atemwegserkrankungen: Die Optimierung der Therapie mit Methylxanthinen. Dtsch Ärzteblatt. 1989;86:1625–30.

    Google Scholar 

  • Haen E, Göpfert C. Tabelle der Stoffwechselwege. In: Klein HG, Haen E, editors. Pharmakogenetik und Therapeutisches Drug Monitoring. Berlin/Boston: Walter de Gruyter GmbH; 2018. p. 60–108. ISBN 978-3-11-035286-3; e-ISBN (PDF) 978-3-11-035290-0, e-ISBN (EPUB) 978-3-11-038780-3.

    Google Scholar 

  • Haen E, Laux G. Arzneimitteltherapiesicherheit/Pharmakovigilanz in der klinischen Psychopharmakotherapie – Das Kliniknetzwerk AGATE. Psychopharmakotherapie. 2011;18:238–43.

    Google Scholar 

  • Haen E, Greiner C, Bader W, Wittmann M. Wirkstoffkonzentrationsbestimmungen zur Therapieleitung - Ergänzung therapeutischer Referenzbereiche durch dosisbezogene Referenzbereiche. Nervenarzt. 2008;79(5):558–66.

    Article  CAS  PubMed  Google Scholar 

  • Haen E, Schwarz M, Pascucci G. Identifizierung von Arzneimittelinteraktionen. In: Klein HG, Haen E, editors. Pharmakogenetik und Therapeutisches Drug Monitoring. Berlin/Boston: Walter de Gruyter GmbH; 2018a. p. 44–9. ISBN 978-3-11-035286-3, e-ISBN (PDF) 978-3-11-035290-0, e-ISBN (EPUB) 978-3-11-038780-3.

    Google Scholar 

  • Haen E, Fay B, Hiemke C. Tabellarische Zusammenstellung der dosisbezogenen und der therapeutischen Referenzbereiche einiger klinisch wichtiger Wirkstoffe. In: Klein HG, Haen E, editors. Pharmakogenetik und Therapeutisches Drug Monitoring. Berlin/Boston: Walter de Gruyter GmbH; 2018b. p. 137–46. ISBN 978-3-11-035286-3, e-ISBN (PDF) 978-3-11-035290-0, e-ISBN (EPUB) 978-3-11-038780-3.

    Google Scholar 

  • Hamelin BA, Allard S, Laplante L, Miceli J, Wilner KD, Tremblay J, Lebel M. The effect of timing of a standard meal on the pharmacokinetics and pharmacodynamics of the novel atypical antipsychotic agent ziprasidone. Pharmacotherapy. 1998;18(1):9–15.

    CAS  PubMed  Google Scholar 

  • Heimann G, Schug S, Bergt U. Pharmacokinetics of combined antibiotic therapy in the newborn infant. Monatsschr Kinderheilkd. 1983;13:58–62.

    Google Scholar 

  • Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsantis G, Schwarz M, Silva Gracia M, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker M, Waschgler R, Zernig G, Zurek G, Baumann P. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2018. Pharmacopsychiatry. 2017;51(01/02):9–62. https://doi.org/10.1055/s-0043-116492. Published online 2017.

    Article  CAS  PubMed  Google Scholar 

  • Holt S, Schmiedl S, Thürmann P. Potentially inappropriate medication in the elderly – PRISCUS list. Dtsch Arztebl Int. 2010;107:543–51.

    PubMed  PubMed Central  Google Scholar 

  • Hosia-Randell HM, Muurinen SM, Pitkala KH. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging. 2008;25(8):683–92.

    Article  CAS  PubMed  Google Scholar 

  • IBM Watson Health Cambridge, MA 02142/USA. 2020. Accessible via https://www.micromedexsolutions.com/micromedex2/librarian/deeplinkaccess?institution=COMMHOS%5eCOMMHOS%5e33486. Accessed 26 Jan 2020.

  • ifap Service-Institut für Ärzte und Apotheker GmbH, Martinsried/Germany. 2020. Accessible via https://www.ifap.de/arzneimitteldaten. Accessed 26 Jan 2020.

  • Johnell K, Fastbom J, Rosen M, Leimanis A. Inappropriate drug use in the elderly: a nation-wide register-based study. Ann Pharmacother. 2007;41(7):1243–8.

    Article  PubMed  Google Scholar 

  • Kazui M, Nishiya Y, Ishizuka T, Hagihara K, Farid NA, Okazaki O, Ikeda T, Kurihara A. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite. Drug Metab Dispos. 2010;38(1):92–9.

    Article  CAS  PubMed  Google Scholar 

  • Klein HG, Haen E. Pharmakogenetik und Therapeutisches Drug Monitoring. Berlin/Boston: Walter de Gruyter GmbH; 2018. p. 20–31. ISBN 978-3-11-035286-3; e-ISBN (PDF) 978-3-11-035290-0, e-ISBN (EPUB) 978-3-11-038780-3.

    Book  Google Scholar 

  • Köstlbacher A. Eine Informationssystem-Infrastruktur für das Therapeutische Drug Monitoring. Planung, Umsetzung und Integration der Wechselwirkungsdatenbank PsiacOnline, des semantischen Wikis OpenDrugWiki.org und des Laborinformationssystems KONBEST. Dissertation Universität Regensburg 2012. Herausgegeben vom Hochschulverband für Informationswissenschaft (HI) e.V. Konstanz (Hrsg.): Schriften zur Informationswissenschaft Band 61. Boi-zenburg: Verlag Werner Hülsbusch; 2012. ISBN 978-3-86488-019-3.

  • Köstlbacher A, Haen E. Konbest – a web-based laboratory information management system (LIMS) for TDM-laboratories. Pharmacopsychiatry. 2008;41:212.

    Google Scholar 

  • Lau WC, Gurbel PA, Watkins PB, Neer CJ, Hopp AS, Carville DG, Guyer KE, Tait AR, Bates ER. Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance. Circulation. 2004;109(2):166–71.

    Article  CAS  PubMed  Google Scholar 

  • Maio V, Yuen EJ, Novielli K, Smith KD, Louis DZ. Potentially inappropriate medication pre-scribing for elderly outpatients in Emilia Romagna, Italy: a population-based cohort study. Drugs Aging. 2006;23(11):915–24.

    Article  PubMed  Google Scholar 

  • Maio V, Del Canale S, Abouzaid S. Using explicit criteria to evaluate the quality of prescribing in elderly Italian outpatients: a cohort study. J Clin Pharm Ther. 2010;35(2):219–29.

    Article  CAS  PubMed  Google Scholar 

  • mediQ – Qualitätszentrum für Medikamentensicherheit, Psychiatrische Dienste Aargau AG, Brugg. Accessible via https://www.mediq.ch. Accessed 27 Jan 2020

  • Medizinische Medien Informations GmbH, Neu-Isenburg/Germany. Accessible via https://www.gelbe-liste.de. Accessed 26 Jan 2020.

  • Newman WG, Hadfield KD, Latif A, Roberts SA, Shenton A, McHague C, Lalloo F, Howell S, Evans DG. Impaired tamoxifen metabolism reduces survival in familial breast cancer patients. Clin Cancer Res. 2008;14(18):5913–8.

    Article  CAS  PubMed  Google Scholar 

  • Nobili A, Pasina L, Mangiagalli A, Marchetti A, Frau S, Zimol R. Farmaci e anziani metodi per gestire l’inappropriatezza prescrittiva. Dialogo sui farmaci. 2012;3:112–20.

    Google Scholar 

  • Oie S, Levy G. Effect of sulfisoxazole on pharmacokinetics of free and plasma protein-bound bilirubin in experimental unconjugated hyperbilirubinemia. J Pharm Sci. 1979;68(1):6–9.

    Article  CAS  PubMed  Google Scholar 

  • Ortlieb J, Baier M, Röder-Aigner J, Müller-Oerlinghausen B, Haen E. Welches Diuretikum bei Lithium-Therapie? Psychopharmakotherapie. 2012;19:275–7.

    Google Scholar 

  • Prudent M, Drame M, Jolly D, Trenque T, Parjoie R, Mahmoudi R, Lang PO, Somme D, Boyer F, La-niece I, Gauvain JB, Blanchard F, Novella JL. Potentially inappropriate use of psychotropic medications in hospitalized elderly patients in France: cross-sectional analysis of the prospective, multicentre SAFEs cohort. Drugs Aging. 2008;25(11):933–46.

    Article  PubMed  Google Scholar 

  • Quick M, Schwarz M, Haen E. Datenbanken zur Identifizierung von Arzneimittelinteraktionen. In: Klein HG, Haen E, editors. Pharmakogenetik und Therapeutisches Drug Monitoring. Berlin/Boston: Walter de Gruyter GmbH; 2018. p. 49–60. ISBN 978-3-11-035286-3.

    Google Scholar 

  • Roche Pharma AG Grenzach-Wyhlen, Germany. Fachinformation (Summary of Product Information) Valium® Tabletten 5 und 10 mg. 2013. issued July 2013.

    Google Scholar 

  • Souci SW, Fachmann W, Kraut H. Die Zusammensetzung der Lebensmittel, Nährwert-Tabellen. 8th ed. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2016.

    Google Scholar 

  • Teva B.V. Haarlem/The Netherlands. Summary of product characteristics for clopidogrel ratiopharm 75 mg film-coated tablets. 2020, issued February 2020.

    Google Scholar 

  • The 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67(4):674–94. https://doi.org/10.1111/jgs.15767.

    Article  Google Scholar 

  • The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104. https://doi.org/10.1093/eurheartj/ehy339.

    Article  Google Scholar 

  • Thiem U. Potentiell inadäquate Medikamente, Qualität der Arzneimitteltherapie bei Älteren. Internist (Berl). 2012;53(9):1125–30.

    Article  CAS  Google Scholar 

  • Thiem U, Hinrichs T, Muller CA, Holt-Noreiks S, Nagl A, Bucchi C, Trampisch U, Moschny A, Platen P, Penner E, Junius-Walker U, Hummers-Pradier E, Theile G, Schmiedl S, Thurmann PA, Scholz S, Greiner W, Klaassen-Mielke R, Pientka L, Trampisch HJ. Voraussetzungen für ein neues Versorgungsmodell für ältere Menschen mit Multimorbidität. Ergebnisse und Schlussfolgerungen aus 3-jähriger Forschung im PRISCUS-Verbund [Prerequisites for a new health care model for elderly people with multiple morbidities: results and conclusions from 3 years of research in the PRISCUS consortium]. Z Gerontol Geriatr. 2011;44(Suppl 2):101–12.

    Article  PubMed  Google Scholar 

  • van der Hooft C, Jong G, Dieleman J, Verhamme K, Van der Cammen T, Stricker B, Sturkenboom M. Inappropiate drug prescribing in older adults: the updated 2002 Beers criteria -a population-based cohort study. Br J Clin Pharmacol. 2005;60(2):137–44.

    Article  PubMed  PubMed Central  Google Scholar 

  • Welling PG. Effects of food on drug absorption. Annu Rev Nutr. 1996;16(1):383–415.

    Article  CAS  PubMed  Google Scholar 

  • Wenzel-Seifert K, Wittmann M, Haen E. QTc prolongation by psychotropic drugs and the risk of torsade de pointes. Dtsch Arztebl Int. 2011;108:687–93. https://doi.org/10.3238/arztebl.2011.0687.

    Article  PubMed  PubMed Central  Google Scholar 

  • Woosley RL, Heise CW, Gallo T, Tate J, Woosley D, Romero KA. QTdrugs List. 2020. www.crediblemeds.org. Accessed 25 Apr 2020. AZCERT (Arizona Center for Education and Research on Therapeutics), Inc., 1822 Innovation Park Drive, Oro Valley, AZ 85755, USA.

  • Wort & Bild Verlag Konradshöhe GmbH & Co. KG Baierbrunn bei München/Germany: Alles Wichtige über Medikamente. 2020. Accessible via https://www.apotheken-umschau.de/Medikamente. Accessed 26 Jan 2020.

  • Wunderer H. Wechselwirkungen mit der Nahrung. Eschborn: Govi Verlag Pharmazeutischer Verlag GmbH; 1998. ISBN 978-3-7741-0702-1.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ekkehard Haen .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Haen, E. (2021). Xenobiotic Interactions in Psychopharmacotherapy: Classification and Handling. In: Riederer, P., Laux, G., Nagatsu, T., Le, W., Riederer, C. (eds) NeuroPsychopharmacotherapy. Springer, Cham. https://doi.org/10.1007/978-3-319-56015-1_10-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56015-1_10-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56015-1

  • Online ISBN: 978-3-319-56015-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics